Citation 33166

SMEE,DF: MC KERNAN,PA: ALAGHAMANDAN,HA: FRANK,KB: RAMASAMY,K: REVANKAR,GR: ROBINS,RK:. (1988). ANTIVIRAL ACTIVITIES OF 2'-DEOXYRIBOFURANOSYL AND ARABINOFURANOSYL ANALOGS OF SANGIVAMYCIN AGAINST RETRO- AND DNA VIRUSES.. 16(6)

Citation Details

Title	ANTIVIRAL ACTIVITIES OF 2'-DEOXYRIBOFURANOSYL AND ARABINOFURANOSYL ANALOGS OF SANGIVAMYCIN AGAINST RETRO- AND DNA VIRUSES.
Authors	SMEE,DF: MC KERNAN,PA: ALAGHAMANDAN,HA: FRANK,KB: RAMASAMY,K: REVANKAR,GR: ROBINS,RK:
Year	1988
Volume	16
Issue	6

Summary

Year: 1988

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,2'-DEOXY: BETA-D-RIBOFURANOSYL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	ACTIVE
13	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	SANGIVAMYCIN,BETA-D-ARABINOFURANOSYL:	INACTIVE

Citation 33166

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1